semaglutide en france Trade group opposes Novo Nordisk's

Some practitioners use compounded semaglutide , which may follow slightly different concentration schedules

GLP-1 receptor agonists cause weight loss primarily by suppressing appetite, slowing gastric emptying to increase fullness, and acting on brain regions that regulate hunger and food cravings

T., & Rodriguez, M

While there is no strong evidence suggesting that these drugs will interact in a harmful way, their different effects on the body can create situations where caution is needed

Good News: Wegovy Is Preferred CVS Caremark (Aetna's pharmacy benefit manager) made Wegovy their preferred GLP-1 in July 2025 after negotiating a deal with Novo Nordisk